ESGEX
Price
$21.28
Change
+$0.13 (+0.61%)
Updated
Sep 5 closing price
Net Assets
95.17M
GFACX
Price
$73.45
Change
+$0.17 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

ESGEX vs GFACX

Header iconESGEX vs GFACX Comparison
Open Charts ESGEX vs GFACXBanner chart's image
Reynders McVeigh Core Equity Instl
Price$21.28
Change+$0.13 (+0.61%)
VolumeN/A
Net Assets95.17M
American Funds Growth Fund of Amer C
Price$73.45
Change+$0.17 (+0.23%)
VolumeN/A
Net Assets331.65B
ESGEX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ESGEX vs. GFACX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESGEX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 332B vs. ESGEX (95.2M). ESGEX pays higher dividends than GFACX: ESGEX (0.51) vs GFACX (0.00). ESGEX was incepted earlier than GFACX: ESGEX (6 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than ESGEX (1.12). ESGEX (25.00) and GFACX (25.00) have comparable annual turnover. GFACX has a lower initial minimum investment than ESGEX: GFACX (250) vs ESGEX (1000). GFACX annual gain was more profitable for investors over the last year : 16.14 vs. ESGEX (13.66). ESGEX return over 5 years is better than : 59.83 vs. GFACX (32.72).
ESGEXGFACXESGEX / GFACX
Total Expense Ratio0.951.3670%
Annual Report Gross Expense Ratio1.121.3682%
Fund Existence6 years24 years-
Gain YTD13.85815.19891%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets95.2M332B0%
Annual Yield % from dividends0.510.00-
Returns for 1 year13.6616.1485%
Returns for 3 years50.1653.1894%
Returns for 5 years59.8332.72183%
Returns for 10 yearsN/A79.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUFRY5.550.05
+0.91%
AVOLTA AG
HLTRF3.80N/A
N/A
HLS Therapeutics Inc.
TRUBF4.87N/A
N/A
TRUECALLER AB
NTDOF89.80-0.64
-0.71%
Nintendo Co., Ltd.
ASAPF0.18-0.01
-3.72%
Aurora Spine Corp